PSN 006
Natural health product licensed in Canada
- Licence holder
- Veevance Inc.
- NPN or DIN-HM
- 80001726
- Status
- Inactive licence
- Licence date
- 10 October 2006
- Revision date
- 6 July 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Artemisia vulgaris L.: L'huile essentielle de cette plante est interdite.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Artemisia vulgaris Source : Parties aériennes Extraction ratio : 4:1 Dry plant equivalent : 800 mg | 200 mg | Not calculated |
| Artemisia vulgaris Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 800 mg | 200 mg | Not calculated |
Non-medicinal ingredients
Cellulose - microcrystalline, Gélatine, Stéarate de magnésium végétal
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Utilisée traditionnellement en phytothérapie pour stimuler l'appétit (orexigène). Utilisée traditionnellement en phytothérapie pour aider à la digestion (stomachique). Utilisée traditionnellement en phytothérapie pour stimuler la sécrétion de la bile (cholérétique).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent.
- Contre-indications
Ne pas utiliser si vous êtes enceinte ou si vous allaitez. Ne pas utiliser en cas d'allergie à la famille des Astéracées / Composées / Marguerites.
- Effets indésirables connus
Une hypersensibilité ou une allergie peuvent se manifester. Si tel est le cas, cesser l'utilisation.
Source
Official Health Canada record, licence 80001726
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging